ONTOLOGY REPORT - ANNOTATIONS
| Term: | decreased tumor incidence |
|
| Accession: | MP:0002052
|
browse the term
|
| Definition: | less than the expected number of neoplasms in a specific population in a given time period |
| Synonyms: | exact_synonym: | decreased neoplasm incidence; increased resistance to neoplasm development; increased resistance to tumor development; reduced tumor incidence |
| | related_synonym: | decreased susceptibility to neoplasm development; decreased susceptibility to tumor development |
| | alt_id: | MP:0005514 |
|
|
decreased hepatoma incidence
|
| Q |
Hcar1 |
Hepatocarcinoma resistance QTL 1 |
|
|
IED |
10 |
6,172,805 |
36,254,741 |
RGD:619598 |
RGD |
| Q |
Hcar10 |
Hepatocarcinoma resistance QTL 10 |
|
|
IED |
8 |
43,313,902 |
87,122,960 |
RGD:629566 |
RGD |
| Q |
Hcar11 |
Hepatocarcinoma resistance QTL 11 |
|
|
IED |
6 |
41,300,997 |
115,238,799 |
RGD:629566 |
RGD |
| Q |
Hcar12 |
Hepatocarcinoma resistance QTL 12 |
|
|
IED |
3 |
25,775,548 |
118,863,223 |
RGD:629566 |
RGD |
| Q |
Hcar13 |
Hepatocarcinoma resistance QTL 13 |
|
|
IED |
4 |
1 |
29,414,068 |
RGD:737884 |
RGD |
| Q |
Hcar14 |
Hepatocarcinoma resistance QTL 14 |
|
|
IED |
18 |
53,847,682 |
86,863,412 |
RGD:737884 |
RGD |
| Q |
Hcar15 |
Hepatocarcinoma resistance QTL 15 |
|
|
IED |
1 |
156,124,624 |
247,322,277 |
RGD:1358145 |
RGD |
| Q |
Hcar2 |
Hepatocarcinoma resistance QTL 2 |
|
|
IED |
4 |
78,035,196 |
135,074,488 |
RGD:619598 |
RGD |
| Q |
Hcar3 |
Hepatocarcinoma resistance QTL 3 |
|
|
IED |
8 |
57,308,572 |
103,684,785 |
RGD:619598 |
RGD |
| Q |
Hcar4 |
Hepatocarcinoma resistance QTL 4 |
|
|
IED |
1 |
198,396,580 |
220,639,653 |
RGD:619609 |
RGD |
| Q |
Hcar5 |
Hepatocarcinoma resistance QTL 5 |
|
|
IED |
1 |
220,639,539 |
232,579,992 |
RGD:619609 |
RGD |
| Q |
Hcar6 |
Hepatocarcinoma resistance QTL 6 |
|
|
IED |
1 |
224,822,211 |
267,910,886 |
RGD:619609 |
RGD |
| Q |
Hcar7 |
Hepatocarcinoma resistance QTL 7 |
|
|
IED |
4 |
58,550,170 |
93,498,821 |
RGD:619609 |
RGD |
| Q |
Hcar8 |
Hepatocarcinoma resistance QTL 8 |
|
|
IED |
|
|
|
RGD:619609 |
RGD |
| Q |
Hcar9 |
Hepatocarcinoma resistance QTL 9 |
|
|
IED |
4 |
106,554,769 |
171,204,531 |
RGD:629566 |
RGD |
decreased incidence of chemically-induced tumors
|
| Q |
Mamtr6 |
Mammary tumor resistance QTL 6 |
|
Induced |
TAS |
18 |
19,892,650 |
86,863,412 |
RGD:2302423 |
RGD |
| Q |
Mamtr7 |
Mammary tumor resistance QTL 7 |
|
Induced |
IED |
10 |
9,762,188 |
108,776,963 |
RGD:2302423 |
RGD |
| Q |
Mamtr8 |
Mammary tumor resistance QTL 8 |
|
Induced |
IED |
18 |
32,458,819 |
86,863,412 |
RGD:2302423 |
RGD |
| S |
SPRD.WKY-(D10Rat91-D10Rat135)/Ibmm |
|
|
Induced |
IED |
10 |
9,762,188 |
108,776,963 |
RGD:2302423 |
RGD |
| S |
SPRD.WKY-(D18Wox8-D18Rat44)/Ibmm |
|
|
|
IED |
18 |
19,892,650 |
86,863,412 |
RGD:1643011 |
RGD |
| S |
SPRD.WKY-(D5Rat190-D5Rat114)/Ibmm |
|
|
|
IED |
5 |
24,978,084 |
24,978,263 |
RGD:1643011 |
RGD |
| S |
SS-Chr 12BN/Mcwi |
|
|
Induced |
IED |
|
|
|
RGD:4143380 |
RGD |
| S |
SS-Chr 14BN/Mcwi |
|
|
Induced |
IED |
|
|
|
RGD:4143380 |
RGD |
| S |
SS-Chr 19BN/Mcwi |
|
|
Induced |
IED |
|
|
|
RGD:4143380 |
RGD |
| S |
SS-Chr 3BN/Mcwi |
|
|
Induced |
IED |
|
|
|
RGD:4143380 |
RGD |
| S |
SS-Chr 5BN/Mcwi |
|
|
Induced |
IED |
|
|
|
RGD:4143380 |
RGD |
| S |
SS-Chr 6BN/Mcwi |
|
|
Induced |
IED |
|
|
|
RGD:4143380 |
RGD |
| S |
SS-Chr 9BN/Mcwi |
|
|
Induced |
IED |
|
|
|
RGD:4143380 |
RGD |
decreased incidence of induced tumors
|
| Q |
Gcr1 |
Gastric cancer resistance QTL 1 |
|
|
QTM |
4 |
144,600,129 |
150,048,167 |
RGD:69698 |
RGD |
| Q |
Gcr2 |
Gastric cancer resistance QTL 2 |
|
|
QTM |
3 |
4,010,230 |
23,762,628 |
RGD:69698 |
RGD |
| Q |
Gcr3 |
Gastric cancer resistance QTL 3 |
|
|
QTM |
16 |
18,121,291 |
70,196,694 |
RGD:69698 |
RGD |
decreased liver tumor incidence
|
| Q |
Hcar15 |
Hepatocarcinoma resistance QTL 15 |
|
|
IED |
1 |
156,124,624 |
247,322,277 |
RGD:1358145 |
RGD |
| Q |
Lnnr1 |
Liver neoplastic nodule remodeling QTL 1 |
|
|
IED |
7 |
38,076,588 |
83,076,588 |
RGD:629574 |
RGD |
| Q |
Lnnr2 |
Liver neoplastic nodule remodeling QTL 2 |
|
|
IED |
1 |
241,199,027 |
267,910,886 |
RGD:629574 |
RGD |
| Q |
Lnnr3 |
Liver neoplastic nodule remodeling QTL 3 |
|
|
IED |
2 |
1 |
41,032,214 |
RGD:737884 |
RGD |
| Q |
Lnnr4 |
Liver neoplastic nodule remodeling QTL 4 |
|
|
IED |
13 |
1 |
43,835,207 |
RGD:737884 |
RGD |
| Q |
Lnnr5 |
Liver neoplastic nodule remodeling QTL 5 |
|
|
IED |
13 |
62,072,299 |
94,306,205 |
RGD:737884 |
RGD |
| Q |
Lnnr6 |
Liver neoplastic nodule remodeling QTL 6 |
|
|
IED |
13 |
78,189,125 |
111,154,910 |
RGD:737884 |
RGD |
decreased mammary gland tumor incidence
|
| Q |
Emca10 |
Estrogen-induced mammary cancer QTL 10 |
|
|
IED |
6 |
1,301,952 |
46,301,952 |
RGD:2292503 |
RGD |
| Q |
Mamtr1 |
Mammary tumor resistance QTL 1 |
|
|
IED |
5 |
12,880,403 |
119,333,229 |
RGD:631852 |
RGD |
| Q |
Mamtr2 |
Mammary tumor resistance QTL 2 |
|
|
IED |
2 |
5,601,528 |
10,539,334 |
RGD:724790 |
RGD |
| Q |
Mamtr3 |
Mammary tumor resistance QTL 3 |
|
|
IED |
2 |
32,051,319 |
43,376,636 |
RGD:724790 |
RGD |
| Q |
Mamtr4 |
Mammary tumor resistance QTL 4 |
|
|
IED |
2 |
14,747,814 |
59,747,814 |
RGD:724790 |
RGD |
| Q |
Mcs28 |
Mammary carcinoma susceptibility QTL 28 |
|
|
IED |
|
|
|
RGD:5684388 |
RGD |
| S |
SPRD.WKY-(D18Wox8-D18Rat44)/Ibmm |
|
|
|
IED |
18 |
19,892,650 |
86,863,412 |
RGD:2302423 |
RGD |
| S |
SPRD.WKY-(D5Rat190-D5Rat114)/Ibmm |
|
|
|
IED |
5 |
24,978,084 |
24,978,263 |
RGD:2302423 |
RGD |
| S |
WF.WKY-(D5Uwm67-D5Uwm98)/Uwm |
|
|
Induced |
IED |
5 |
79,919,505 |
79,919,776 |
RGD:5684388 |
RGD |
| S |
WF.WKY-(D5Uwm76-D5Got18)/Uwm |
|
|
Induced |
IED |
5 |
82,406,661 |
82,406,827 |
RGD:5684388 |
RGD |
| S |
WF.WKY-(D5Uwm76-D5Uwm61)/Uwm |
|
|
Induced |
IED |
5 |
84,434,303 |
84,434,576 |
RGD:5684388 |
RGD |
| S |
WF.WKY-(D5Uwm76-D5Uwm92)/Uwm |
|
|
Induced |
IED |
|
|
|
RGD:5684388 |
RGD |
| S |
WF.WKY-(D5Uwm76-D5Uwm98)/Uwm |
|
|
Induced |
IED |
|
|
|
RGD:5684388 |
RGD |
| S |
WF.WKY-(D5Uwm77-D5Uwm91)/Uwm |
|
|
|
IED |
|
|
|
RGD:5684388 |
RGD |
| S |
WF.WKY-(D5Uwm78-D5Uwm93)/Uwm |
|
|
Induced |
IED |
|
|
|
RGD:5684388 |
RGD |
| S |
WF.WKY-(D5Uwm78-D5Uwm98)/Uwm |
|
|
Induced |
IED |
5 |
82,406,661 |
82,406,827 |
RGD:5684388 |
RGD |
| S |
WF.WKY-(D5Uwm82-D5Uwm91)/Uwm |
|
|
|
IED |
|
|
|
RGD:5684388 |
RGD |
| S |
WF.WKY-(D5Uwm82-D5Uwm92)/Uwm |
|
|
|
IED |
|
|
|
RGD:5684388 |
RGD |
| S |
WF.WKY-(D5Uwm85-D5Uwm92)/Uwm |
|
|
|
IED |
|
|
|
RGD:5684388 |
RGD |
| S |
WKY/NHsd |
|
|
|
IED |
|
|
|
RGD:1581951 |
RGD |
decreased tongue tumor incidence
|
| Q |
Tcat1 |
Tongue tumor resistance QTL 1 |
|
|
QTM |
1 |
101,971,983 |
146,971,983 |
RGD:61091 |
RGD |
Term paths to the root
|